Evidence
Cell Biochem Biophys. 2024 Jul 10. doi: 10.1007/s12013-024-01395-6. Online ahead of print.
ABSTRACT
Even though RNA treatments were first proposed as a way to change aberrant signaling in cancer, research in this field is currently ongoing. The term “RNAi” refers to the use of several RNAi technologies, including ribozymes, riboswitches, Aptamers, small interfering RNA (siRNA), antisense oligonucleotides (ASOs), and CRISPR/Cas9 technology. The siRNA therapy has already achieved a remarkable feat by revolutionizing the treatment arena of cancers. Unlike small molecules and antibodies, which need administration every three months or even every two years, RNAi may be given every quarter to attain therapeutic results. In order to overcome complex challenges, delivering siRNAs to the targeted tissues and cells effectively and safely and improving the effectiveness of siRNAs in terms of their action, stability, specificity, and potential adverse consequences are required. In this context, the three primary techniques of siRNA therapies for hepatocellular carcinoma (HCC) are accomplished for inhibiting angiogenesis, decreasing cell proliferation, and promoting apoptosis, are discussed in this review. We also deliberate targeting issues, immunogenic reactions to siRNA therapy, and the difficulties with their intrinsic chemistry and transportation.
PMID:38987439 | DOI:10.1007/s12013-024-01395-6
Estimated reading time: 4 minute(s)
Latest: Psychiatryai.com #RAISR4D Evidence
Cool Evidence: Engaging Young People and Students in Real-World Evidence
Real-Time Evidence Search [Psychiatry]
AI Research
Recent Advances in RNA Interference-Based Therapy for Hepatocellular Carcinoma: Emphasis on siRNA
🌐 90 Days
AI Virtual Reality Related Evidence Matrix
- Recent Advances in RNA Interference-Based Therapy for Hepatocellular Carcinoma: Emphasis on siRNA
- Biocompatible hydroxyapatite-based nano vehicle bypasses viral transduction and enables sustained silencing of a pluripotency marker gene, demonstrating desired differentiation in mouse embryonic stem cells
- RNAi-mediated silencing of SOD1 profoundly extends survival and functional outcomes in ALS mice
- Antisense RNA C9orf72 hexanucleotide repeat associated with amyotrophic lateral sclerosis and frontotemporal dementia forms a triplex-like structure and binds small synthetic ligand
- ARID5B is a negative modulator of IL-6 production in rheumatoid arthritis synovial fibroblasts
- RNA modifications in the progression of liver diseases: from fatty liver to cancer
- RNA modifications in the progression of liver diseases: from fatty liver to cancer
- Neoadjuvant nivolumab with or without relatlimab in resectable non-small-cell lung cancer: a randomized phase 2 trial
- Efficacy and mechanism of action of Yanxiao Di'naer formula for non-alcoholic steatohepatitis treatment based on metabolomics and RNA sequencing
- Efficacy and mechanism of action of Yanxiao Di'naer formula for non-alcoholic steatohepatitis treatment based on metabolomics and RNA sequencing
- The lncRNA Malat1 is trafficked to the cytoplasm as a localized mRNA encoding a small peptide in neurons
- Targeting LINC070974 inhibits lung adenocarcinoma cell proliferation and progression by interacting with Y-box binding protein 1
- Application and challenge of pathomics technique in the management of hepatocellular carcinoma
- Brusatol induces ferroptosis to inhibit hepatocellular carcinoma progression by targeting ATF3
- tRNA anticodon cleavage by target-activated CRISPR-Cas13a effector
- Myospreader improves gene editing in skeletal muscle by myonuclear propagation
- Role of FXR in the development of NAFLD and intervention strategies of small molecules
- The multifaceted functions of long non-coding RNA HOTAIR in neuropathologies and its potential as a prognostic marker and therapeutic biotarget
- The multifaceted functions of long non-coding RNA HOTAIR in neuropathologies and its potential as a prognostic marker and therapeutic biotarget
- CAR-NKT Cells in Asthma: Use of NKT as a Promising Cell for CAR Therapy
- CAR-NKT Cells in Asthma: Use of NKT as a Promising Cell for CAR Therapy
- Expression of concern: A hypoxia-dissociable siRNA nanoplatform for synergistically enhanced chemo-radiotherapy of glioblastoma
- Cell-type-specific loops linked to RNA polymerase II elongation in human neural differentiation
- Expression of concern: A hypoxia-dissociable siRNA nanoplatform for synergistically enhanced chemo-radiotherapy of glioblastoma
- Mapping medically relevant RNA isoform diversity in the aged human frontal cortex with deep long-read RNA-seq
- A review on cell-Free RNA Profiling: insights into metabolic diseases and predictive value for bariatric surgery outcomes
- Molecular and epigenetic ex vivo profiling of testis cancer-associated fibroblasts and their interaction with germ cell tumor cells and macrophages
- The potential of the nutraceutical berberine in the treatment of hepatocellular carcinoma and other liver diseases such as NAFLD and NASH
- TaqTth-hpRNA: a novel compact RNA-targeting tool for specific silencing of pathogenic mRNA
- TaqTth-hpRNA: a novel compact RNA-targeting tool for specific silencing of pathogenic mRNA
- Screening for pancreatic cancer in high-risk individuals using MRI: optimization of scan techniques to detect small lesions
- A case series of non-small cell lung cancer patients with EGFR or HER2 exon 20 insertion in Li Fraumeni syndrome
- A case series of non-small cell lung cancer patients with EGFR or HER2 exon 20 insertion in Li Fraumeni syndrome
- Spatial genomics: mapping human steatotic liver disease
- Effects of local reduction of endogenous α-synuclein using antisense oligonucleotides on the fibril-induced propagation of pathology through the neural network in wild-type mice
- The impact of IDR phosphorylation on the RNA binding profiles of proteins
- The impact of IDR phosphorylation on the RNA binding profiles of proteins
- Small cell neuroendocrine carcinoma and poorly differentiated rhabdomyosarcomas of the urinary bladder in adults-A comparative analysis in favor of a common histogenesis
- Small cell neuroendocrine carcinoma and poorly differentiated rhabdomyosarcomas of the urinary bladder in adults-A comparative analysis in favor of a common histogenesis
- Iron metabolism: backfire of cancer cell stemness and therapeutic modalities
- MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons
- Crystal structure of a tetrameric RNA G-quadruplex formed by hexanucleotide repeat expansions of C9orf72 in ALS/FTD
- Novel KCNQ2 missense variant expands the genotype spectrum of DEE7
- Novel KCNQ2 missense variant expands the genotype spectrum of DEE7
- Targeting the Hippo pathway to prevent radioresistance brain metastases from the lung (Review)
- Multiscale approaches for understanding single cell spatial omics data
- Pathological autoantibody internalisation in myositis
- Moss-m7G: A Motif-Based Interpretable Deep Learning Method for RNA N7-Methlguanosine Site Prediction
- Hepatitis B virus particles in serum contain minus strand DNA and degraded pregenomic RNA of variable and inverse lengths
- Screening for urothelial carcinoma cells in urine based on digital holographic flow cytometry through machine learning and deep learning methods
- SRSF2 promotes glioblastoma cell proliferation by inducing alternative splicing of FSP1 and inhibiting ferroptosis
- SRSF2 promotes glioblastoma cell proliferation by inducing alternative splicing of FSP1 and inhibiting ferroptosis
- Ocular A-to-I RNA editing signatures associated with SARS-CoV-2 infection
- Hepatocellular Carcinoma: Prevention, Diagnosis, and Treatment
- Huntingtin is an RNA binding protein and participates in NEAT1-mediated paraspeckles
- Impact and Interrelationships of Striatal Proteins, EPHB2, OPRM1, and PER2 on Mild Cognitive Impairment
- Integrating analysis of mRNA expression profiles indicates Sgk1 as a key mediator in muscle-brain crosstalk during resistance exercise
- AI identifies potent inducers of breast cancer stem cell differentiation based on adversarial learning from gene expression data
- The Role of CD4+T Cells in Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma
- Lipid Nanoparticle-Mediated Delivery of CRISPR-Cas9 Against Rubicon Ameliorates NAFLD by Modulating CD36 Along with Glycerophospholipid Metabolism
- Tartaric acid ameliorates experimental non-alcoholic fatty liver disease by activating the AMP-activated protein kinase signaling pathway
- Tartaric acid ameliorates experimental non-alcoholic fatty liver disease by activating the AMP-activated protein kinase signaling pathway
- Pathophysiology of cerebral small vessel disease: a journey through recent discoveries
- Identification of RNA‐dependent liquid‐liquid phase separation proteins using an artificial intelligence strategy
Evidence Blueprint
Recent Advances in RNA Interference-Based Therapy for Hepatocellular Carcinoma: Emphasis on siRNA
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
Recent Advances in RNA Interference-Based Therapy for Hepatocellular Carcinoma: Emphasis on siRNA
🌐 365 Days
AI Virtual Reality Related Evidence Matrix
- Recent Advances in RNA Interference-Based Therapy for Hepatocellular Carcinoma: Emphasis on siRNA
- Small-interfering RNA targeting proprotein convertase subtilisin/kexin type 9 might promote fatty liver disease and hepatocellular carcinoma through upregulation of CD36
- Biocompatible hydroxyapatite-based nano vehicle bypasses viral transduction and enables sustained silencing of a pluripotency marker gene, demonstrating desired differentiation in mouse embryonic stem cells
- Protocol for gene knockdown using siRNA in primary cultured neonatal murine microglia
- METTL3 drives NAFLD-related hepatocellular carcinoma and is a therapeutic target for boosting immunotherapy
- The advent of RNA-based therapeutics for metabolic syndrome and associated conditions: a comprehensive review of the literature
- Combined RNA interference and gene replacement therapy targeting MFN2 as proof of principle for the treatment of Charcot-Marie-Tooth type 2A
- Anti-EGFR ScFv functionalized exosomes delivering LPCAT1 specific siRNAs for inhibition of lung cancer brain metastases
- Gene Silencing and Gene Delivery in Therapeutics: Insights Using Quantum Dots
- RNAi-mediated silencing of SOD1 profoundly extends survival and functional outcomes in ALS mice
- Retrotransposon addiction promotes centromere function via epigenetically activated small RNAs
- Antisense RNA C9orf72 hexanucleotide repeat associated with amyotrophic lateral sclerosis and frontotemporal dementia forms a triplex-like structure and binds small synthetic ligand
- ARID5B is a negative modulator of IL-6 production in rheumatoid arthritis synovial fibroblasts
- RNA modifications in the progression of liver diseases: from fatty liver to cancer
- RNA modifications in the progression of liver diseases: from fatty liver to cancer
- RNA therapeutics for neurological disease
- Elucidating the role of intrinsic adenosine A1 receptors in acute alcoholism using human induced pluripotent stem cell-derived hepatocytes
- Quantifying the activity profile of ASO and siRNA conjugates in glioblastoma xenograft tumors in vivo
- Neoadjuvant nivolumab with or without relatlimab in resectable non-small-cell lung cancer: a randomized phase 2 trial
- Efficacy and mechanism of action of Yanxiao Di'naer formula for non-alcoholic steatohepatitis treatment based on metabolomics and RNA sequencing
- Efficacy and mechanism of action of Yanxiao Di'naer formula for non-alcoholic steatohepatitis treatment based on metabolomics and RNA sequencing
- Characterization of ribosome stalling and no-go mRNA decay stimulated by the Fragile X protein, FMRP
- Recent advances in the management of hepatocellular carcinoma
- The lncRNA Malat1 is trafficked to the cytoplasm as a localized mRNA encoding a small peptide in neurons
- Evaluation of Antisense Oligonucleotides Therapy Targeting Hsd17b13 in a Fibrosis Mice Model
- In Vitro Prostate Cancer Treatment via CRISPR-Cas9 Gene Editing Facilitated by Polyethyleneimine-Derived Graphene Quantum Dots
- Targeting LINC070974 inhibits lung adenocarcinoma cell proliferation and progression by interacting with Y-box binding protein 1
- Viral Vector-Based Gene Therapy for Epilepsy: What Does the Future Hold?
- Advance and Application of Single-cell Transcriptomics in Auditory Research
- Advancements in Single-Cell RNA Sequencing Research for Neurological Diseases
- HIV-1 mRNA knockdown with CRISPR/CAS9 enhances neurocognitive function
- Restoring the Function of Thalamocortical Circuit Through Correcting Thalamic Kv3.2 Channelopathy Normalizes Fear Extinction Impairments in a PTSD Mouse Model
- Application and challenge of pathomics technique in the management of hepatocellular carcinoma
- Inhibition of DAPK3 suppresses radiation-induced cellular senescence by activation of a PGC1alpha-dependent metabolism pathway in brain endothelial cells
- Changes in RBM47 expression based on the timing of melatonin administration and its effects on Nrf2 activity in the hippocampus
- Brusatol induces ferroptosis to inhibit hepatocellular carcinoma progression by targeting ATF3
- Molecular dynamics in multidimensional space explains how mutations affect the association path of neomycin to a riboswitch
- ErbB4 affects Th1/Th17 cell differentiation and promotes psoriasis progression
- Hepatocellular and extrahepatic cancer risk in people with non-alcoholic fatty liver disease
- Translation dysregulation in neurodegenerative diseases: a focus on ALS
- Transcriptomics of Human Brain Tissue in Parkinson's Disease: a Comparison of Bulk and Single-cell RNA Sequencing
- Evaluation of the interest to combine a CD4 Th1-inducer cancer vaccine derived from telomerase and atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma: a randomized non-comparative phase II study (TERTIO - PRODIGE 82)
- Phenylalanine-tRNA aminoacylation is compromised by ALS/FTD-associated C9orf72 C4G2 repeat RNA
- Emerging roles of RNA-binding proteins in fatty liver disease
- tRNA anticodon cleavage by target-activated CRISPR-Cas13a effector
- Interferon-a receptor antisense oligonucleotides reduce neuroinflammation and neuropathology in a mouse model of cerebral interferonopathy
- Novel epigenetic molecular therapies for imprinting disorders
- Investigating the Role of Non-Coding RNA in Non-Alcoholic Fatty Liver Disease
- Dissecting viral infections, one cell at a time, by single-cell technologies
- Reversal of C9orf72 mutation-induced transcriptional dysregulation and pathology in cultured human neurons by allele-specific excision
- Haploinsufficiency of phosphodiesterase 10A activates PI3K/AKT signaling independent of PTEN to induce an aggressive glioma phenotype
- Genome-wide CRISPR screens identify noncanonical translation factor eIF2A as an enhancer of SARS-CoV-2 programmed -1 ribosomal frameshifting
- Myospreader improves gene editing in skeletal muscle by myonuclear propagation
- Role of FXR in the development of NAFLD and intervention strategies of small molecules
- The multifaceted functions of long non-coding RNA HOTAIR in neuropathologies and its potential as a prognostic marker and therapeutic biotarget
- The multifaceted functions of long non-coding RNA HOTAIR in neuropathologies and its potential as a prognostic marker and therapeutic biotarget
- CAR-NKT Cells in Asthma: Use of NKT as a Promising Cell for CAR Therapy
- CAR-NKT Cells in Asthma: Use of NKT as a Promising Cell for CAR Therapy
- Expression of concern: A hypoxia-dissociable siRNA nanoplatform for synergistically enhanced chemo-radiotherapy of glioblastoma
- Cell-type-specific loops linked to RNA polymerase II elongation in human neural differentiation
- Expression of concern: A hypoxia-dissociable siRNA nanoplatform for synergistically enhanced chemo-radiotherapy of glioblastoma
- Single-Cell RNA-Sequencing in Astrocyte Development, Heterogeneity, and Disease
- Mapping medically relevant RNA isoform diversity in the aged human frontal cortex with deep long-read RNA-seq
- Alphaviruses in cancer immunotherapy